etoposide has been researched along with Intellectual Disability in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Abe, K; Dowsett, L; Hutchins, K; Wada, R | 1 |
Fukami, T; Nitta, N; Nozaki, K | 1 |
Jereb, B; Macedoni-Luksic, M; Todorovski, L | 1 |
Finlay, JL; McElwain, M; Packer, RJ; Pons, MA; Puccetti, D; Walker, RW | 1 |
1 review(s) available for etoposide and Intellectual Disability
Article | Year |
---|---|
Germinoma in two brothers: case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Dwarfism; Etoposide; Family Health; Germinoma; Humans; Hydrocephalus; Hypothyroidism; Intellectual Disability; Male; Siblings; Supratentorial Neoplasms; Tectum Mesencephali; Ventriculoperitoneal Shunt; Vision Disorders; Young Adult | 2013 |
1 trial(s) available for etoposide and Intellectual Disability
Article | Year |
---|---|
Chemotherapy with vincristine (VCR) and etoposide (VP-16) in children with low-grade astrocytoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Etoposide; Female; Growth Disorders; Hematologic Diseases; Humans; Infant; Intellectual Disability; Male; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Nervous System Diseases; Radiation Injuries; Remission Induction; Salvage Therapy; Treatment Outcome; Vincristine | 1992 |
2 other study(ies) available for etoposide and Intellectual Disability
Article | Year |
---|---|
A pediatric case of acute myeloid leukemia with KMT2A gene rearrangement t(10;11) and 16p11.2 microdeletion syndrome.
Topics: Antineoplastic Agents; Autistic Disorder; Child; Chromosome Deletion; Chromosome Disorders; Chromosomes, Human, Pair 16; Cytarabine; Daunorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Histone-Lysine N-Methyltransferase; Humans; Intellectual Disability; Leukemia, Myeloid, Acute; Mitogen-Activated Protein Kinase 3; Myeloid-Lymphoid Leukemia Protein; Vault Ribonucleoprotein Particles | 2021 |
Long-term sequelae in children treated for brain tumors: impairments, disability, and handicap.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Atrophy; Brain; Brain Damage, Chronic; Brain Neoplasms; Calcinosis; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disabled Children; Epilepsy; Etoposide; Female; Humans; Hydrocephalus; Infant; Intellectual Disability; Learning Disabilities; Lomustine; Magnetic Resonance Imaging; Male; Methotrexate; Movement Disorders; Neoplasm Recurrence, Local; Prevalence; Procarbazine; Radiation Injuries; Slovenia; Survivors; Tomography, X-Ray Computed; Unemployment; Vincristine; Vision Disorders | 2003 |